Immunotherapy for Tuberculosis: What's the better choice?

Frontiers in Bioscience

Volumn 17, Issue 7, 2011, Pages 2684-2690

  Guo, Shuliang ^a   Zhao, Jinqiu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxic T lymphocyte; Review; rh IFN ; TNF ; Tuberculosis

Indexed keywords

MYCOBACTERIUM VACCAE;

EID: 84860303998     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4079     Document Type: Article

References (32)

1. Krutzik SR, Hewison M, Liu PT: IL-15 links TLR2/1 induced macrophage differentiation to the vitamin Ddependent antimicrobial pathway. J Immunol 181, 7115-71120 (2008)
2. Harris J, De Haro SA, Master SS: T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27, 505-517 (2007) (Pubitemid 47418681)
3. Reljic R, Paul M J, Arias M A: Cytokine therapy of tuberculosis at the crossroads. Expert Rev Resp Med 3, 53-66 (2009)
4. Hewitson JP, Grainger JR, Maizels RM: Helminth immuno regulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol 167, 1-11 (2009)
5. Rook GA, Lowrie DB, Hernndez-Pando R: Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols? J Infect Dis 196:191-198 (2007) (Pubitemid 47047457)
6. Roy E, Lowire DB, Jolles SR: Current Strategies in TB immuno therapy. Curr Mol Med 77, 373-386 (2007)
7. Achkar JM, Casadevall A, Glatman-Freedman A: Immunological options for the treatment of tuberculosis:evaluation of novel therapeutic approaches. Expert Rev Anti Infect Ther 5, 461-474 (2007) (Pubitemid 47053758)
8. Condos R, Rom WN, Schluger NW: Treatment of multidrug-resistant pulmonary tuberculosis with interferongamma via aerosol. Lancet 349, 1513-1515 (1997) (Pubitemid 27216363)
9. Koh WJ, Kwon OJ, Suh GY: Six month therapy with aerosolized interferon for refractory multidrug-resistant pulmonary tuberculosis. J Korean Med Sci 19, 167-171 (2004) (Pubitemid 38591787)
10. Raju B, Hoshino Y, Kuwabara K: Aerosolized gamma interferon (IFN-gamma)Induces expression of the genes encoding the IFN-gamma-inducible 10-kilo-dalton protein but not inducible nitricoxide synthase in the lung during Tuberculosis. Infect Immun 72, 1275-1283 (2004) (Pubitemid 38263745)
11. Kuchtey J, Fulton SA, Reba SM, Harding CV, Boom WH: Interferon mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guerin infection. Immunology 118, 39-49 (2006)
12. Johnson JL, Ssekasanvu E, Okwera A: Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. Am J Respir Crit Care Med 168, 185-191 (2003) (Pubitemid 36920972)
13. Johnson BJ, Bekker LG, Rickman R: rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo. Tuber Lung Dis 78, 1950-203 (1997)
14. Barnes PF: Immunotherapy for tuberculosis-wave of the future or tilting at windmills ? Am J Resp Crit Care Med 168, 185-191 (2003)
15. Feng CG, Jankovic D, Kullberg M: Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol 174, 4185-4192 (2005) (Pubitemid 40395997)
16. Elas-Lpez AL, Marquina B, Gutirrez-Ortega A: Transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis. Clin Exp Immunol 154:123-133 (2008)
17. Algood HM, Lin PL, Yankura D: TNF influences chemokine expression of macrophages in vitro and that of CD11b1 cells in vivo during Mycobacterium tuberculosis infection. J Immunol 172, 6846-6857 (2004) (Pubitemid 38669123)
18. Skomsvoll JF, Wallenius M, Koksvik HS: Drug insight: anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nat Clin Rheumatol 3, 156-164 (2007) (Pubitemid 46416264)
19. Wallis RS, Broder M, Wong J, Beenhouwer D. Granulomatous infections due to tumor necrosis factor blockade: correction. Clin Infect Dis 39, 1254-1255 (2004) (Pubitemid 40169331)
20. Wallis RS, Kyambadde P, Johnson JL: A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. AIDS 18, 257-264 (2004) (Pubitemid 38253448)
21. Elias D, Akuffo H, Pawlowski A: Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent mycobacterium tuberculosis. Vaccine 23, 1326-1334 (2005) (Pubitemid 40127324)
22. Mayanja-Kizza H, Jones-Lopez E, Okwera A, et al. Immuno adjuvant prednisolone therapy for HIV-associated tuberculosis: a Phase 2 clinical trial in Uganda. J Infect Dis 191, 856-865 (2005) (Pubitemid 40349799)
23. Buccheri S, Reljic R, Caccamo N: IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice. Eur J Immunol 37, 729-737 (2007) (Pubitemid 46916939)
24. Rook GAW, Dheda K, Zumla A: Do successful tuberculosis vaccines need to be immuno regulatory rather than merely Th1-boosting? Vaccine 23, 21150-2120 (2005)
25. Hernandez-Pando R, Orozco-Esteves H, Maldonado HA: A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis. Clin Exp Immunol 144, 264-272 (2006)
26. Zuany-Amorim C, Sawicka E, Manlius C: Suppression of airway eosinophiliaby killed mycobacterium vaccaeinduced allergen-specific regulatory T-cells. Nat Med 8, 625-629 (2002) (Pubitemid 34633442)
27. Roy E, Stavropoulos E, Brennan J: Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice. Infect Immun 73, 6101-6109 (2005) (Pubitemid 41193049)
28. Hamasur B, Haile M, Pawlowski A: A mycobacterial lipoarabinomannan specific monoclonal antibody and its F (ab') 2 fragment prolong survival of mice infected with mycobacterium tuberculosis. Clin Exp Immunol 138, 30-38 (2004) (Pubitemid 39279962)
29. Luo Y: The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 24, 43-47 (2001)
30. Ricklin-Gutzwiller ME, Reist M, Peel JE: Intradermal injection of heat-killed Mycobacterium vaccae in dogs with atopic dermatitis: a multicentre pilot study. Vet Dermatol 18, 87-93 (2007) (Pubitemid 46393258)
31. de Bruyn G, Garner P: Mycobacterium vaccae immunotherapy for treating tuberculosis. The Cochrane Library Issue1 (2010)
32. Zarate-Blades CR, Bonato VL, da Silveira EL: Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNA HSP65 immunotherapy. J Gene Med 11, 66-78 (2009)